Sequana Medical signs collaboration agreement with Fresenius Medical Care for the marketing and distribution of the alfapump® system

Zurich, Switzerland: 16 April 2015 - Sequana Medical, a Swiss-based medical device company, announced today that it has entered into an agreement with Fresenius Medical Care to commercialize its innovative alfapump system.
The alfapump system is an automated, fully implantable pump system for the management of ascites. Ascites is a frequent complication of late-stage liver disease and certain cancers, and affects hundreds of thousands of patients across the world.

More info on Sequana's website.  

Next > iSTAR Medical appoints medical device executive Michel Lussier as Chairman of its Board of Directors

Previous > NGDATA Fuels data-driven strategy for Belgium energy company